Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.47 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11930692 | 0.88 | ALDH1A1 (0.57) | MEN1KMT2AALDH1A1HPGDLMNA | |
| SCHEMBL27728450 | 0.85 | NR3C1 (0.53) | MEN1KMT2AALDH1A1HPGDLMNA | |
| SCHEMBL4920981 | 0.83 | CHRM3 (0.48) | MEN1KMT2AALDH1A1HPGDCHRM3 | |
| SCHEMBL4922992 | 0.82 | ALDH1A1 (0.49) | MEN1KMT2AALDH1A1HPGDCHRM3 | |
| SCHEMBL4918689 | 0.82 | CHRM3 (0.50) | MEN1KMT2AALDH1A1HPGDCHRM3 | |
| SCHEMBL1134832 | 0.82 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1HPGDCHRM3 | |
| SCHEMBL1085555 | 0.81 | LMNA (0.61) | MEN1KMT2AALDH1A1LMNACYP1A2 | |
| SCHEMBL3540095 | 0.81 | CHRM3 (0.46) | MEN1KMT2ANTRK1ABCG2ALDH1A1 | |
| SCHEMBL3540046 | 0.81 | ABCG2 (0.45) | MEN1KMT2ANTRK1ABCG2ALDH1A1 | |
| SCHEMBL9979664 | 0.80 | LMNA (0.45) | MEN1KMT2AABCG2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7799334-B2 | Pyrazolecarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2010-09-21 | — | — | US | claimed |
| US-20090203523-A1 | Fungicidal Mixtures Made From 1-Methylpyrazol-4-Ylcarboxanilides | BASF AKTIENGESSELLSCHFT (DE) | 2009-08-13 | — | — | US | claimed |
| US-20090036305-A1 | PYRAZOLECARBOXAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-05 | — | — | US | claimed |
| CN-101175727-A | Pyrazole carboxamides as fungicides | BASF AG (DE) | 2008-05-07 | — | — | CN | claimed |
| US-7799334-B2 | Pyrazolecarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2010-09-21 | — | — | US | disclosed |
| US-20090203523-A1 | Fungicidal Mixtures Made From 1-Methylpyrazol-4-Ylcarboxanilides | BASF AKTIENGESSELLSCHFT (DE) | 2009-08-13 | — | — | US | disclosed |
| US-20090036305-A1 | PYRAZOLECARBOXAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-05 | — | — | US | disclosed |
| CN-101175727-A | Pyrazole carboxamides as fungicides | BASF AG (DE) | 2008-05-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203523-A1 | Fungicidal Mixtures Made From 1-Methylpyrazol-4-Ylcarboxanilides | CTRL, CYP4X1, SNU13 | MEN1 792/4885KMT2A 1745/4885NTRK1 3524/4885 |
| US-20090036305-A1 | PYRAZOLECARBOXAMIDES | CBR3, CBR1, CYC1 | MEN1 2257/4885KMT2A 1627/4885NTRK1 3863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.